[Mental disorders in the course of L-dopa treatment].
D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy
D004295:Dihydroxyphenylalanine
Zaburzonia psychiczne w przebiegu leczenia L-dopa.